JP2011508791A5 - - Google Patents

Download PDF

Info

Publication number
JP2011508791A5
JP2011508791A5 JP2010542440A JP2010542440A JP2011508791A5 JP 2011508791 A5 JP2011508791 A5 JP 2011508791A5 JP 2010542440 A JP2010542440 A JP 2010542440A JP 2010542440 A JP2010542440 A JP 2010542440A JP 2011508791 A5 JP2011508791 A5 JP 2011508791A5
Authority
JP
Japan
Prior art keywords
lactide
drug depot
implantable drug
fluocinolone
biodegradable polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010542440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011508791A (ja
Filing date
Publication date
Priority claimed from US12/413,197 external-priority patent/US9125917B2/en
Application filed filed Critical
Publication of JP2011508791A publication Critical patent/JP2011508791A/ja
Publication of JP2011508791A5 publication Critical patent/JP2011508791A5/ja
Pending legal-status Critical Current

Links

JP2010542440A 2008-04-18 2009-04-17 生物分解性ポリマー担体中のフルオシノロン製剤 Pending JP2011508791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4621808P 2008-04-18 2008-04-18
US12/413,197 US9125917B2 (en) 2008-04-18 2009-03-27 Fluocinolone formulations in a biodegradable polymer carrier
PCT/US2009/041043 WO2009129511A2 (en) 2008-04-18 2009-04-17 Fluocinolone formulations in a biodegradable polymer carrier

Publications (2)

Publication Number Publication Date
JP2011508791A JP2011508791A (ja) 2011-03-17
JP2011508791A5 true JP2011508791A5 (enExample) 2011-05-12

Family

ID=41199779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010542440A Pending JP2011508791A (ja) 2008-04-18 2009-04-17 生物分解性ポリマー担体中のフルオシノロン製剤

Country Status (5)

Country Link
US (2) US9125917B2 (enExample)
EP (1) EP2280712A4 (enExample)
JP (1) JP2011508791A (enExample)
CN (1) CN101959520A (enExample)
WO (1) WO2009129511A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090110637A1 (en) * 2007-10-26 2009-04-30 Warsaw Orthopedic, Inc. LMP and Regulation of Tissue Growth
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
US20110027331A1 (en) * 2009-07-29 2011-02-03 Warsaw Orthopedic, Inc. An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
EP3691618A1 (en) 2017-10-06 2020-08-12 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
CN116650732A (zh) 2018-01-08 2023-08-29 铸造疗法股份有限公司 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法
EP3752239A4 (en) 2018-02-13 2021-11-03 Kieran P. Murphy DELIVERY SYSTEM FOR IMAGE-CONTROLLED DELIVERY OF A DRUG DEPOT TO A DESTINATION, AND PROCEDURES AND USES THEREOF
US12458589B2 (en) 2018-05-12 2025-11-04 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents
EP3843710A1 (en) 2018-08-28 2021-07-07 Foundry Therapeutics, Inc. Polymer implants
US12383246B2 (en) 2020-10-12 2025-08-12 Abbott Cardiovascular Systems, Inc. Vessel closure device with improved safety and tract hemostasis

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624255A (en) 1982-02-18 1986-11-25 Schenck Robert R Apparatus for anastomosing living vessels
US4863457A (en) 1986-11-24 1989-09-05 Lee David A Drug delivery device
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5868789A (en) 1997-02-03 1999-02-09 Huebner; Randall J. Removable suture anchor apparatus
US5522844A (en) 1993-06-22 1996-06-04 Johnson; Lanny L. Suture anchor, suture anchor installation device and method for attaching a suture to a bone
DE69603577T2 (de) * 1995-02-10 1999-11-25 Medtronic, Inc. Verfahren und vorrichtung zur verabreichung von analgetika
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
ATE318580T1 (de) 1996-12-20 2006-03-15 Alza Corp Gelzusammensetzungen und verfahren
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
IL129951A0 (en) 1997-07-02 2000-02-29 Euro Celtique Sa Prolonged anesthesia in joints and body spaces
TW577758B (en) 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
US6069129A (en) 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
EP1077653B1 (en) 1998-05-12 2004-03-31 Boston Scientific Limited Manual bone anchor placement devices
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6436099B1 (en) 1999-04-23 2002-08-20 Sdgi Holdings, Inc. Adjustable spinal tether
US6287588B1 (en) 1999-04-29 2001-09-11 Macromed, Inc. Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
US7220281B2 (en) 1999-08-18 2007-05-22 Intrinsic Therapeutics, Inc. Implant for reinforcing and annulus fibrosis
US7951201B2 (en) 1999-10-20 2011-05-31 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
DK1244388T3 (da) 1999-12-06 2007-05-14 Warsaw Orthopedic Inc Indretning til behandling af mellemhvirvelskiver
US6899716B2 (en) 2000-02-16 2005-05-31 Trans1, Inc. Method and apparatus for spinal augmentation
US6589549B2 (en) 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
DE60137542D1 (de) 2001-01-03 2009-03-12 Bausch & Lomb Wirkstoffabgabevorrichtungen mit verzögerter freisetzung mehrere stoffe enthaltend
US20030152637A1 (en) 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
US7229441B2 (en) 2001-02-28 2007-06-12 Warsaw Orthopedic, Inc. Flexible systems for spinal stabilization and fixation
US7235043B2 (en) 2001-03-09 2007-06-26 Boston Scientific Scimed Inc. System for implanting an implant and method thereof
MXPA01011542A (es) 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US6974462B2 (en) 2001-12-19 2005-12-13 Boston Scientific Scimed, Inc. Surgical anchor implantation device
EP1531757B1 (en) 2002-07-19 2016-09-07 Omeros Corporation Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
US20040137059A1 (en) * 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant
US20040166088A1 (en) 2003-01-15 2004-08-26 Shalaby Shalaby W. Polymeric precursors of non-absorbable, in situ-forming hydrogels and applications thereof
US7144412B2 (en) 2003-06-25 2006-12-05 Wolf Medical Enterprises, Inc. Gold suture and method of use in wound closure
ATE410186T1 (de) * 2003-06-26 2008-10-15 Control Delivery Sys Inc In-situ gelierendes arzneimittelabgabesystem
PT1638535E (pt) * 2003-06-26 2007-11-08 Mediolanum Pharmaceuticals Ltd Implantes subcutâneos com libertação inicial de princípio activo limitada e subsequente sua libertação extensiva com variação linear
WO2005046746A2 (en) 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
JP2007519756A (ja) 2004-01-30 2007-07-19 アンジオテック インターナショナル アーゲー 拘縮を治療するための組成物および方法
US20050226814A1 (en) * 2004-04-13 2005-10-13 Bausch & Lomb Incorporated Diagnostic method and kit for implantation of a sustained release drug-delivery implant with a steroid
US7410480B2 (en) 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US7361168B2 (en) 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
WO2005121394A1 (ja) * 2004-06-07 2005-12-22 Ulvac, Inc. マグネトロンスパッタリング方法及びマグネトロンスパッタリング装置
MX2007003968A (es) * 2004-10-01 2008-03-04 Ramscor Inc Composiciones de farmaco de liberacion sostenida convenientemente implantables.
CN101119713A (zh) 2004-11-24 2008-02-06 阿尔高克斯制药公司 类辣椒素凝胶制剂及其用途
US7611494B2 (en) 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
US7610100B2 (en) 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US7741273B2 (en) 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20080091207A1 (en) 2006-10-13 2008-04-17 Csaba Truckai Bone treatment systems and methods

Similar Documents

Publication Publication Date Title
Yang et al. Medical applications and prospects of polylactic acid materials
RU2010111357A (ru) Составы, содержащие клонидин в разлагаемом полимере
US8883183B2 (en) Medical devices incorporating collagen inhibitors
WO2009129509A4 (en) Methods and compositions for treating post-operative pain comprising a local anesthetic
JP2011508788A5 (enExample)
JP2011508789A5 (enExample)
WO2009129437A4 (en) Methods and compositions for treating post-operative pain comprising clonidine
WO2012075447A4 (en) Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
UA111162C2 (uk) Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
WO2011016881A4 (en) An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
Wang et al. Biodegradable intestinal stents: a review
MX2012010611A (es) Dispositivos implantables heterogeneos para suministro de medicamento.
JP2014156496A5 (ja) 生分解性眼内インプラント
WO2009129510A4 (en) Sulindac formulations in a biodegradable material
WO2009129147A4 (en) Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
JP2004210798A5 (enExample)
Pothupitiya et al. Synthetic biodegradable polyesters for implantable controlled-release devices
CN102573981A (zh) 可展开装置及其使用方法
WO2012075440A4 (en) Compositions and methods for delivering clonidine to a target tissue site
WO2009129511A4 (en) Fluocinolone formulations in a biodegradable polymer carrier
WO2008024626A3 (en) Bioresorbable stent with extended in vivo release of anti-restenotic agent
WO2009129453A4 (en) Clonidine formulation in a polyorthoester carrier
JPWO2016114216A1 (ja) 生分解性ステント
EA202192878A1 (ru) Способ лечения ребенка с преждевременным половым созреванием центрального генеза с использованием композиции с пролонгированным высвобождением
Ning et al. On-demand prolongation of peripheral nerve blockade through bupivacaine-loaded hydrogels with suitable residence periods